JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) (USD $)	12 Months Ended		101 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$ 6,000,000		$ 6,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)	600,000
Joint Venture Method Investment Ownership Percentage	60.00%
Joint Venture Investments In Non Voting Preferred Ownership Units	5,000,000
Payments to Acquire Long-term Investments	3,300,000
Joint Venture Investments Common Ownership Units, Coventure (in shares)	400,000
Ownership Percentage Coventure	40.00%
Cash paid for assets of AzERx/CBI	0	0	4,058,000
Percentage Of Royalty Payment	3.00%
Development Activities Monthly Fee	63,000
Accounting and Administrative Monthly Fee	10,000
Investments In and Advance To Affiliates Additional Performance Measured Incentive Fee	250,000
Joint Venture Losses Recognition Criteria, Common Ownership Equity	0		0
Joint Venture, Operating Expenses, Inter Company Transactions			50,000
Joint Venture, Operating Expenses Incurred			1,183,000
Joint Venture, Operating Expenses Allocated To Company			710,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest	473,000
Percentage Of Non Royalty Income	15.00%
Exclusive License Agreement [Member]
Annual Maintenance Payments	25,000
Exclusive License Agreement [Member] | Maximum [Member]
Milestone Payments	1,000,000
Royalty Expense	5,000,000
Exclusive License Agreement [Member] | Minimum [Member]
Milestone Payments	50,000
Royalty Expense	1,000,000
Lipimetix [Member]
Cash paid for assets of AzERx/CBI	378,000		4,436,000
Corporate Joint Venture [Member]
Investments In and Advance To Affiliates Additional Performance Measured Incentive Fee	2,700,000		2,700,000
Voting Common Ownership Units [Member]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	1,000,000		1,000,000
Non Voting Preferred Ownership Units [Member]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$ 5,000,000		$ 5,000,000